Submitted by Anonymous (not verified) on 27 January 2026 - 15:55
Human medicines European public assessment report (EPAR): Minjuvi, tafasitamab, Date of authorisation: 26/08/2021, Revision: 12, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Minjuvi, tafasitamab, Date of authorisation: 26/08/2021, Revision: 12, Status: Authorised